<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39316851</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5616</ISSN><JournalIssue CitedMedium="Internet"><Volume>237</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>23</Day></PubDate></JournalIssue><Title>Public health</Title><ISOAbbreviation>Public Health</ISOAbbreviation></Journal><ArticleTitle>Frailty trends in Catalonia 2017-2021: An epidemiological study with 1.5 million people aged ≥65 years.</ArticleTitle><Pagination><StartPage>14</StartPage><EndPage>21</EndPage><MedlinePgn>14-21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.puhe.2024.09.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0033-3506(24)00398-6</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Knowledge of frailty prevalence and incidence trends over time is essential for planning the necessary health and social resources. The objective of this study was to assess frailty prevalence, incidence, reversibility and mortality rates, and trends for the population aged ≥65 years in Catalonia over the period 2017-2021.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Longitudinal epidemiological study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">An observational longitudinal 5-year study (1 January 2017 to 31 December 2021) of the population aged ≥65 years in Catalonia (approximately 1.5 million individuals) was performed using retrospectively collected data from different health databases. Frailty status was evaluated using the electronic Screening Index of Frailty (e-SIF) and categorised as robust, pre-frail, moderately frail or severely frail.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Standardised frailty prevalence rates were 10.5 % (2017), 11.8 % (2018), 13.1 % (2019), 12.9 % (2020) and 14.3 % (2021) [p-value for trend = 0.010]. Standardised frailty incidence rates per 1000 non-frail persons/year were 35 (2018), 36 (2019), 28 (2020) and 33 (2021) [p-value for trend = 0.492]. Both prevalence and incidence were higher in women and increased with age. Standardised frailty reversibility rates per 1000 frail persons/year were 123 (2018), 108 (2019) and 121 (2020) [p-value for trend = 0.406], and decreased with age. Standardised mortality rates for frail individuals per 1000 frail persons/year were 93 (2018), 84 (2019) and 110 (2020) [p-value for trend = 0.555], and increased with frailty severity.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Frailty prevalence in Catalonia increased by 36 % between 2017 and 2021; however, no clear trend was evident for frailty incidence and reversibility, while results for mortality were likely to have been influenced by the COVID-19 pandemic.</AbstractText><CopyrightInformation>Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Serra-Prat</LastName><ForeName>Mateu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Unit, Consorci Sanitari del Maresme, Mataró, Barcelona, Spain; Networked Biomedical Research Centre for Liver and Digestive Diseases (CIBEREHD), Madrid, Spain; Germans Trias i Pujol Research Institute, Badalona, Barcelona, Spain. Electronic address: mserra@csdm.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Carmona</LastName><ForeName>Ma Rosario</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Oncology, Hospital de Mataró, Consorci Sanitari del Maresme, Mataró, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortuny</LastName><ForeName>Aida</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Primary Care Department, Institut Català de la Salut, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavado</LastName><ForeName>Àngel</ForeName><Initials>À</Initials><AffiliationInfo><Affiliation>Information Management Unit, Consorci Sanitari del Maresme, Mataró, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papiol</LastName><ForeName>Mònica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Primary Care Department, Consorci Sanitari del Maresme, Mataró, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muñoz</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Datexbio SL, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez-Cerdá</LastName><ForeName>Juan Francisco</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Agency for Health Quality and Assessment of Catalonia (AQUAS), Department of Health, Catalan Government, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serra-Colomer</LastName><ForeName>Júlia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Universities and Research, Catalan Government, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burdoy</LastName><ForeName>Emili</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Primary Care Department, Consorci Sanitari del Maresme, Mataró, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabré</LastName><ForeName>Mateu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Hospital de Mataró, Consorci Sanitari del Maresme, Mataró, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Public Health</MedlineTA><NlmUniqueID>0376507</NlmUniqueID><ISSNLinking>0033-3506</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Frailty</Keyword><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword><Keyword MajorTopicYN="N">Reversibility</Keyword><Keyword MajorTopicYN="N">Trend</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>18</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>18</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>18</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39316851</ArticleId><ArticleId IdType="doi">10.1016/j.puhe.2024.09.016</ArticleId><ArticleId IdType="pii">S0033-3506(24)00398-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle>